Methiopropamine
Methiopropamine (also known as MPA) is a thiophene-ring-based structural analog of methamphetamine originally reported in 1942. Chemically it is not a phenethylamine or amphetamine and is not their functional analog either, which makes it a perfectly legal drug that circumvents even the anti-drug-analog laws. It has been sold as a designer drug, first being identified in Sweden in the year 2010.
Chemistry[edit]
Methiopropamine is related to methamphetamine in much the same way as thiopental is related to pentobarbital. It is not a barbiturate but it is a thiophene analog.
Pharmacology[edit]
Methiopropamine functions as a selective norepinephrine-dopamine reuptake inhibitor with little to no effect on serotonin reuptake. Methiopropamine has a significantly reduced potency compared to methamphetamine, likely due to the added bulk of the thiophene ring. Methiopropamine is likely to be metabolized in a similar way to methamphetamine.
Effects[edit]
The effects of methiopropamine are generally regarded as less intense than methamphetamine but longer lasting than the effects of cocaine. The effects have been described as euphoric, mentally stimulating, and physically stimulating.
Legal Status[edit]
Methiopropamine is a controlled substance in some countries such as the UK, but remains legal in many other jurisdictions. It is often used as a research chemical and can be purchased online.
See Also[edit]
Methiopropamine gallery[edit]
-
Methiopropamine 2D Skeletal
-
Methiopropamine
-
Methiopropamine Metabolism Colored
-
Methiopropamine Synthesis
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
